<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR155">
 <label>155.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bonam</surname>
    <given-names>SR</given-names>
   </name>
   <name>
    <surname>Kaveri</surname>
    <given-names>SV</given-names>
   </name>
   <name>
    <surname>Sakuntabhai</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Gilardin</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Bayry</surname>
    <given-names>J</given-names>
   </name>
  </person-group>
  <article-title>Adjunct immunotherapies for the management of severely Ill COVID-19 patients</article-title>
  <source>Cell Rep Med</source>
  <year>2020</year>
  <volume>1</volume>
  <issue>2</issue>
  <fpage>100016</fpage>
  <pub-id pub-id-type="doi">10.1016/j.xcrm.2020.100016</pub-id>
  <?supplied-pmid 32562483?>
  <pub-id pub-id-type="pmid">32562483</pub-id>
 </element-citation>
</ref>
